English Latvian
Published: 2011-12-09 08:55:04 CET
Olainfarm
Company Announcement

Third Quarter 2011 Investor Conference Webinar

On December 9 AS „Olainfarm” organized its third quarter 2011 Investor Conference Online Webinar for investors. During the webinar the member of the management board of AS „Olainfarm” Salvis Lapiņš informed about the expansion plans of AS „Olainfarm” and analysed the financial results of third quarter, 2011.

Salvis Lapiņš informed that in the year 2012 AS „Olainfarm” forsees non-consolidated sales growth of 12% and indicated that, while the company reaches sufficient targeted profits, it is planned to pay out dividends, which could constitute 10% of the annual profit.

Currently AS „Olainfarm” is not planning a new share issue, as the company has no big investment projects planned in upcoming years.

The recorded Olainfarm webinar is available online: ej.uz/OLFvebinars and the presentation is available here.


Olainfarm thanks all participants, who joined the webinar!

 

 

AS Olainfarm is one of the biggest pharmaceutical companies in Latvia with nearly 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 30 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.    

         Information prepared by:
         Salvis Lapins
         Member of the Board
         AS Olainfarm
         Cell: +371 26448873
         e-mail: Salvis.Lapins@olainfarm.lv